PMID- 38057540 OWN - NLM STAT- MEDLINE DCOM- 20240202 LR - 20240207 IS - 1432-2218 (Electronic) IS - 0930-2794 (Print) IS - 0930-2794 (Linking) VI - 38 IP - 2 DP - 2024 Feb TI - ReSleeve or revisional one anastomosis gastric bypass for failed primary sleeve gastrectomy with dilated gastric tube: a retrospective study. PG - 787-798 LID - 10.1007/s00464-023-10609-6 [doi] AB - BACKGROUND: Revisional bariatric surgery (RBS) has been increasingly performed due to weight loss failure (WLF). Many revisional procedures have been proposed after primary laparoscopic sleeve gastrectomy (pLSG) failure, including ReSleeve gastrectomy (ReLSG), and laparoscopic one anastomosis gastric bypass (LOAGB). Choosing the RBS post-pLSG failure represents a challenge. WLF without gastric tube (GT) dilation is undoubtedly converted to a malabsorptive procedure, but the presence of GT dilation makes it more difficult to select a RBS. This study aimed to compare two relatively simple revisional procedures after pLSG failure with dilated GT to help decision making on which procedure better done to which patient. METHODS: Data of 52 patients who completed one year follow-up (FU) after their RBS (ReLSG: 27 or LOAGB: 25) for their failed pLSG were collected, assessed, correlated to weight loss (WL) and compared. RESULTS: Mean operative time was 97 +/- 18.4 min. with revisional LOAGB (RLOAGB) and 62 +/- 11 min. with ReLSG. Six patients (11.5%) had seven postoperative procedure-specific complications. Significant hemorrhage occurred in three patients. Two cases of leakage were encountered with each procedure. LOAGB Patients had lower mean final weight (76.2 +/- 10.5 vs 85.3 +/- 13), lower mean Final BMI (26.4 +/- 2.5 vs 29.7 +/- 2.9) and higher mean percentage of excess weight loss (EWL%) (83.6 +/- 13.5% vs 60.29 +/- 14.6%). All RLOAGB patients and 77.8% of ReLSG patients had EWL% > 50%. RLOAGB patients had higher EWL% compared to ReLSG (p < 0.001). Insufficient WL (IWL) patients had higher EWL% compared to weight regain (WR) patients (p = 0.034). CONCLUSION: Both procedures (RLOAGB and ReLSG) were relatively safe and effective in terms of WL. RLOAGB led to higher WL compared to ReLSG in all types of patients despite higher Caloric intake. IWL patients had more WL compared to WR patients. WL was not related to GT dilation type. Large-scale longer-FU studies are still needed. TRIAL REGISTRATION: PACTR202310644487566 (retrospectively registered). CI - (c) 2023. The Author(s). FAU - Gerges, Wadie Boshra AU - Gerges WB AUID- ORCID: 0000-0001-7029-1200 AD - Department of General Surgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt. wadie.boshra@med.asu.edu.eg. FAU - Omar, Ahmed S M AU - Omar ASM AD - Department of General Surgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt. FAU - Shoka, Ahmed Ain AU - Shoka AA AD - Department of General Surgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt. FAU - Hamed, Mohammed Abdalmegeed AU - Hamed MA AD - Department of General Surgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt. FAU - Abdelrahim, Hossam S AU - Abdelrahim HS AD - Department of General Surgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt. FAU - Makram, Fady AU - Makram F AD - Department of General Surgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt. LA - eng PT - Journal Article DEP - 20231206 PL - Germany TA - Surg Endosc JT - Surgical endoscopy JID - 8806653 SB - IM MH - Humans MH - *Gastric Bypass/methods MH - *Obesity, Morbid/surgery MH - Retrospective Studies MH - *Laparoscopy/methods MH - Reoperation/methods MH - Gastrectomy/methods MH - Weight Loss MH - Postoperative Complications/etiology/surgery MH - Treatment Outcome PMC - PMC10830658 OTO - NOTNLM OT - Dilated gastric tube OT - LSG OT - Laparoscopic one anastomosis gastric bypass OT - Resleeve OT - Revisional bariatric surgery OT - Weight loss failure COIS- Wadie Boshra Gerges, Ahmed S.M. Omar, Ahmed Ain Shoka, Mohammed Abdalmegeed Hamed, Hossam S. Abdelrahim and Fady Makram have no conflicts of interest or financial ties to disclose. EDAT- 2023/12/07 00:42 MHDA- 2024/02/02 06:43 PMCR- 2023/12/06 CRDT- 2023/12/06 23:41 PHST- 2023/10/11 00:00 [received] PHST- 2023/11/17 00:00 [accepted] PHST- 2024/02/02 06:43 [medline] PHST- 2023/12/07 00:42 [pubmed] PHST- 2023/12/06 23:41 [entrez] PHST- 2023/12/06 00:00 [pmc-release] AID - 10.1007/s00464-023-10609-6 [pii] AID - 10609 [pii] AID - 10.1007/s00464-023-10609-6 [doi] PST - ppublish SO - Surg Endosc. 2024 Feb;38(2):787-798. doi: 10.1007/s00464-023-10609-6. Epub 2023 Dec 6.